Literature DB >> 32207066

Japanese clinical practice guidelines for vascular anomalies 2017.

Hidefumi Mimura1, Sadanori Akita2, Akihiro Fujino3, Masatoshi Jinnin4, Mine Ozaki5, Keigo Osuga6, Hiroki Nakaoka7, Eiichi Morii8, Akira Kuramochi9, Yoko Aoki10, Yasunori Arai11, Noriko Aramaki12, Masanori Inoue13, Yuki Iwashina5, Tadashi Iwanaka14, Shigeru Ueno15, Akihiro Umezawa16, Michio Ozeki17, Junko Ochi18, Yoshiaki Kinoshita19, Masakazu Kurita20, Shien Seike21, Nobuyuki Takakura22, Masataka Takahashi16, Takao Tachibana23, Kumiko Chuman24, Shuji Nagata25, Mitsunaga Narushima26, Yasunari Niimi27, Shunsuke Nosaka28, Taiki Nozaki29, Kazuki Hashimoto11, Ayato Hayashi30, Satoshi Hirakawa31, Atsuko Fujikawa11, Yumiko Hori8, Kentaro Matsuoka32, Hideki Mori7, Yuki Yamamoto4, Shunsuke Yuzuriha33, Naoaki Rikihisa34, Shoji Watanabe35, Shinichi Watanabe36, Tatsuo Kuroda37, Shunsuke Sugawara38, Kosuke Ishikawa39, Satoru Sasaki40.   

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

Entities:  

Keywords:  Clinical practice; Guidelines; Hemangioma; Vascular anomalies; Vascular malformation

Mesh:

Year:  2020        PMID: 32207066      PMCID: PMC7150662          DOI: 10.1007/s11604-019-00885-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  350 in total

1.  Dye laser treatment of port-wine stains.

Authors:  Y Bandoh; A Yanai; K Tsuzuki
Journal:  Aesthetic Plast Surg       Date:  1990       Impact factor: 2.326

2.  Refractory congenital chylous ascites.

Authors:  Antônio Aldo Melo-Filho; Ivana Jesus Nogueira Souza; Christiane Araújo Chaves Leite; Robério Dias Leite; João Henrique Freitas Colares; Júlio Marcus Sousa Correia
Journal:  Indian J Pediatr       Date:  2010-09-07       Impact factor: 1.967

3.  Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy.

Authors:  B Haluk Güvenç; Gülşen Ekingen; Ayşe Tuzlaci; Ufuk Senel
Journal:  Pediatr Surg Int       Date:  2005-06-02       Impact factor: 1.827

4.  Use of the radial forearm artery for secondary embolization of an extensive life-threatening arteriovenous malformation of the mid-face and anterior skull base - a case report.

Authors:  Michael A Ermer; Ralf Gutwald; Martin Schumacher; Rainer Schmelzeisen; Christian Taschner
Journal:  J Craniomaxillofac Surg       Date:  2012-12-14       Impact factor: 2.078

5.  Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.

Authors:  R R Sadykov; F Podmelle; R A Sadykov; K R Kasimova; H R Metellmann
Journal:  Int J Oral Maxillofac Surg       Date:  2013-04-22       Impact factor: 2.789

6.  Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor.

Authors:  Brandie J Metz; Melissa C Rubenstein; Moise L Levy; Denise W Metry
Journal:  Arch Dermatol       Date:  2004-07

7.  Multicenter prospective study of ulcerated hemangiomas.

Authors:  Sarah L Chamlin; Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Ilona J Frieden; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Denise W Metry; Brandon Newell; Amy Jo Nopper; Anthony J Mancini
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

8.  Involution of infantile haemangiomas after imiquimod 5% cream.

Authors:  R B M Barry; B R Hughes; L J Cook
Journal:  Clin Exp Dermatol       Date:  2008-05-15       Impact factor: 3.470

9.  GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation.

Authors:  Jun Q Mo; Haytham H Dimashkieh; Kevin E Bove
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

10.  Treatment of venous malformations with sclerosant in microfoam form.

Authors:  Juan Cabrera; Juan Cabrera; Ma Antonia Garcia-Olmedo; Pedro Redondo
Journal:  Arch Dermatol       Date:  2003-11
View more
  1 in total

1.  Lymphangioma Cavernosum with a Rare Location.

Authors:  Justyna Smaga; Oskar Kornasiewicz; Bogna Ziarkiewicz-Wróblewska; Joanna Podgórska; Piotr Krawczyk; Michał Grąt; Marek Krawczyk
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.